Form D · Pharmaceuticals

HealthMed Corp

Newark, NJ · CIK 0001630968

Offering snapshot reported Mar 9, 2015 · SEC filing

Reported sold
Yet to sell
Offering amount: $2M
Investors reported
0
Form D · investor count
Minimum accepted
$20K
Reported outside-investor minimum
First sale
Yet to occur
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

  • Minimum accepted$25,000 → $20,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 9, 2015AmendmentYet to sellNo comparison0SEC filing
Feb 19, 2015AmendmentYet to sellNo comparison0SEC filing
Jan 27, 2015AmendmentYet to sellNo comparison0SEC filing
Jan 16, 2015InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Equity
Exemptions
06c
Duration over one year
No
Business combination
No
Sales commissions
$160K
Finders' fees
$0
Form D file number
021-232412
Contracted to Provide 8% of Aggregate Cash Purchase Price Upon Closing, to Healthios Capital Markets, LLC

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Healthios Capital Markets, LLC115542

Source: Form D, filed Mar 9, 2015. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Greg Tyler Allison Director, Executive
Eugenio A Cefali Promoter
Peter Marchesini Director
Phillip Patrick Director
Michael A Santoro Director
Allen J Taylor Promoter

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
250 Central Ave Ste 113
Newark, NJ, 07103